{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:25:42Z","timestamp":1757453142348},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00509084","type":"journal-article","created":{"date-parts":[[2004,11,16]],"date-time":"2004-11-16T16:32:57Z","timestamp":1100622777000},"page":"299-303","source":"Crossref","is-referenced-by-count":6,"title":["High doses of antigen-nonspecific IgG do not inhibit pemphigus acantholysis in skin organ cultures"],"prefix":"10.1007","volume":"277","author":[{"given":"T.","family":"Hunziker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U. E.","family":"Nydegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. J.","family":"Sp\ufffdth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. A.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Wiesmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/0003-4819-92-3-396","volume":"92","author":"AR Ahmed","year":"1980","unstructured":"Ahmed AR, Graham J, Jordon RE, Provost TT (1980) Pemphigus: current concepts. Ann Intern Med 92:396?405","journal-title":"Ann Intern Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archderm.1983.01650330003004","volume":"119","author":"GJ Anhalt","year":"1983","unstructured":"Anhalt GJ, Patel H, Diaz LA (1983) Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid. Arch Dermatol 119:711?714","journal-title":"Arch Dermatol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/B978-0-12-057550-3.50053-3","volume-title":"Progress in immunology","author":"J-C Bystryn","year":"1971","unstructured":"Bystryn J-C, Schenkein I, Uhr JW (1971) A model for the regulation of antibody synthesis by serum antibody. In: Amos B (ed) Progress in immunology. Academic Press, New York, pp 627?636"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1073\/pnas.75.1.459","volume":"75","author":"RM Farb","year":"1978","unstructured":"Farb RM, Dykes R, Lazarus GS (1978) Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci USA 75:459?463","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","first-page":"69","volume-title":"7S-Immunglobulin zur intraven\u00f6sen Anwendung. Beitr Infusionstherapie klin Ern\u00e4hr, vol 9","author":"A Fateh-Moghadam","year":"1982","unstructured":"Fateh-Moghadam A, Besinger U, Geursen RG (1982) Ein klinisches Modell zur Regulation der humoralen Immunantwort. In: Seiler FR, Geursen RG (eds) 7S-Immunglobulin zur intraven\u00f6sen Anwendung. Beitr Infusionstherapie klin Ern\u00e4hr, vol 9. Karger, Basel, pp 69?79"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2141.1983.tb02023.x","volume":"53","author":"B Gross","year":"1983","unstructured":"Gross B, Haessig A, Luescher EF, Nydegger UE (1983) Monomeric IgG preparations for intravenous use inhibit platelet stimulation by polymeric IgG. Br J Haematol 53:289?299","journal-title":"Br J Haematol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1084\/jem.157.1.259","volume":"157","author":"K Hashimoto","year":"1983","unstructured":"Hashimoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH (1983) Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med 157:259?272","journal-title":"J Exp Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2340\/0001555563115121","volume":"63","author":"J Hietanen","year":"1983","unstructured":"Hietanen J, Salo OP, Kariniemi A-L (1983) Pemphigus serum-induced loss of microvilli from human epidermal cells. Acta Derm Venereol (Stockh) 63:115?121","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"CR9","first-page":"1637","volume":"111","author":"T Hunziker","year":"1981","unstructured":"Hunziker T, Schwarzenbach HR, Krebs A, Nydegger UE, Camponovo F, Hess M (1981) Plasmaaustausch bei Pemphigus vulgaris. Schweiz Med Wochenschr 111:1637?1642","journal-title":"Schweiz Med Wochenschr"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","volume":"1","author":"P Imbach","year":"1981","unstructured":"Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Sch\u00f6ni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228?1231","journal-title":"Lancet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF01639032","volume":"8","author":"E Liehl","year":"1980","unstructured":"Liehl E, Armerding D, B\u00f6ckmann J (1980) Effektorfunktionen und protektive Wirkung von Standardimmunglobulin und Immunoglobulin nach modifizierter milder S\u00e4urebehandlung. Infection 8:194?198","journal-title":"Infection"},{"key":"CR12","first-page":"231","volume-title":"Immunopathology of the skin","author":"B Michel","year":"1979","unstructured":"Michel B, Schiltz JR (1979) In vitro studies on the mechanism of acantholysis in pemphigus: Organ culture and cell suspension studies. In: Beutner EH, Chorzelski TP, Bean SF (eds) Immunopathology of the skin, 2nd edn. John Wiley and Sons, New York, pp 231?242","edition":"2nd edn."},{"key":"CR13","first-page":"17","volume-title":"Immunohemotherapy","author":"A Morell","year":"1981","unstructured":"Morell A, Riesen W (1981) Structure, function and catabolism of immunoglobulins. In: Nydegger UE (ed) Immunohemotherapy. Academic Press, London, pp 17?26"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/1523-1747.ep12519988","volume":"76","author":"S Morioka","year":"1981","unstructured":"Morioka S, Naito K, Ogawa H (1981) The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. J Invest Dermatol 76:337?341","journal-title":"J Invest Dermatol"},{"key":"CR15","unstructured":"Nydegger UE, Imbach P, Grau GE Prospects for therapy of autoimmune disease with immunoglobulins prepared for intravenous use. In: Lambert PH, Izui S, Perrin LH (eds) Recent advances in SLE. Academic Press, London (in press)"},{"key":"CR16","doi-asserted-by":"crossref","unstructured":"Roitt IM, Male DK, Cooke A, Lydyard PM (1983) Idiotypes and autoimmunity. In: Lambert PH (ed) Immunopathology of idiotypic interactions. Springer Semin Immunopathol 6:51?66","DOI":"10.1007\/BF01857366"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000460851","volume":"42","author":"J R\u00f6mer","year":"1982","unstructured":"R\u00f6mer J, Morgenthaler J-J, Scherz R, Skvaril F (1982) Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content. Vox Sang 42:62?73","journal-title":"Vox Sang"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000460851","volume":"42","author":"J R\u00f6mer","year":"1982","unstructured":"R\u00f6mer J, Sp\u00e4th PJ, Skvaril F, Nydegger UE (1982) Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A. Vox Sang 42:74?80","journal-title":"Vox Sang"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(82)70036-2","volume":"6","author":"WM Sams","year":"1982","unstructured":"Sams WM, Gammon WR (1982) Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol 6:431?449","journal-title":"J Am Acad Dermatol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2133.1965.tb14602.x","volume":"77","author":"I Sarkany","year":"1965","unstructured":"Sarkany I, Grice K, Caron GA (1965) Organ culture of adult human skin. Br J Dermatol 77:65?76","journal-title":"Br J Dermatol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/1523-1747.ep12543775","volume":"74","author":"JR Schiltz","year":"1980","unstructured":"Schiltz JR (1980) Pemphigus acantholysis: a unique immunological injury. J Invest Dermatol 74:359?362","journal-title":"J Invest Dermatol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2133.1979.tb05620.x","volume":"101","author":"JR Schiltz","year":"1979","unstructured":"Schiltz JR, Hu C-H, Michel B (1979) Corticosteroids, aurothioglucose and soybean trypsin inhibitor do not prevent pemphigus antibody-induced acantholysis in vitro. Br J Dermatol 101:279?284","journal-title":"Br J Dermatol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/1523-1747.ep12541618","volume":"73","author":"JR Schiltz","year":"1979","unstructured":"Schiltz JR, Michel B, Papay R (1979) Appearance of ?pemphigus acantholysis factor? in human skin cultured with pemphigus antibody. J Invest Dermatol 73:575?581","journal-title":"J Invest Dermatol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/1523-1747.ep12543780","volume":"74","author":"KH Singer","year":"1980","unstructured":"Singer KH, Sawka NJ, Samowitz HR, Lazarus GS (1980) Proteinase activation: a mechanism for cellular dyshesion in pemphigus. J Invest Dermatol 74:363?367","journal-title":"J Invest Dermatol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0733-8635(18)31035-0","volume":"1","author":"KH Singer","year":"1983","unstructured":"Singer KH, Hashimoto K, Lazarus GS (1983) Pathophysiology of pemphigus. Dermatol Clin 1:179?186","journal-title":"Dermatol Clin"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-68702-0_3","volume-title":"Immunodermatology","author":"KH Singer","year":"1983","unstructured":"Singer KH, Hashimoto K, Lazarus GS (1983) Antibody-induced proteinase activation: a proposed mechanism for pemphigus. In: Gigli IN, Miescher PA, M\u00fcller-Eberhard HJ (eds) Immunodermatology. Springer, Berlin Heidelberg New York, pp 19?34"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/268245a0","volume":"268","author":"G Stingl","year":"1977","unstructured":"Stingl G, Wolff-Schreiner EC, Pichler WJ, Gschnait F, Knapp W, Wolff K (1977) Epidermal Langerhans cells bear Fc and C3 receptors. Nature 268:245?246","journal-title":"Nature"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(84)90701-3","volume":"2","author":"Y Sultan","year":"1984","unstructured":"Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE (1984) Anti-idiotypic suppression of autoantibodies to factor VIII (anti-haemophilic factor) by high-dose intravenous gammaglobulin. Lancet 2:765?768","journal-title":"Lancet"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/1523-1747.ep12518278","volume":"81","author":"DL Swanson","year":"1983","unstructured":"Swanson DL, Dahl MV (1983) Methylprednisolone inhibits pemphigus acantholysis in skin cultures. J Invest Dermatol 81:258?260","journal-title":"J Invest Dermatol"},{"key":"CR30","first-page":"719","volume":"30","author":"TY Woo","year":"1982","unstructured":"Woo TY, Barouski-Miller PA, Gelehrter TD, Patel H, Anhalt GJ, Diaz LA (1982) Molecular mechanisms of pemphigus antibody action. Clin Res 30:719","journal-title":"Clin Res"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"115s","DOI":"10.1111\/1523-1747.ep12540871","volume":"81","author":"TY Woo","year":"1983","unstructured":"Woo TY, Hogan VA, Patel H, Anhalt GJ, Labib RS, Voorhees JJ, Diaz LA (1983) Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol 81:115s-121s","journal-title":"J Invest Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00509084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00509084\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00509084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T11:47:11Z","timestamp":1705319231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00509084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00509084"],"URL":"https:\/\/doi.org\/10.1007\/bf00509084","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}